[HTML] plos.org

[HTML][HTML] Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - PLoS One, 2014 - journals.plos.org
Background Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …
被引用次数：62 相关文章

Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - PLoS ONE, 2014 - go.gale.com
Background Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …

Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis.

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - PLoS ONE, 2014 - search.ebscohost.com
Background: Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …
[PDF] semanticscholar.org

[PDF][PDF] Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - PLoS ONE, 2014 - pdfs.semanticscholar.org
Background: Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …

Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - PLOS ONE, 2014 - ideas.repec.org
Background: Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …

Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis.

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - Plos one, 2014 - europepmc.org
Background Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …
[HTML] nih.gov

[HTML][HTML] Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - PLoS ONE, 2014 - ncbi.nlm.nih.gov
Background Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …

Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - PloS one, 2014 - pubmed.ncbi.nlm.nih.gov
Background Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …
[PDF] psu.edu

[PDF][PDF] Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - PLoS ONE, 2014 - Citeseer
Background: Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …

Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis

G Jiang, RH Li, C Sun, YQ Liu, JN Zheng - PLOS ONE, 2014 - econpapers.repec.org
Background: Malignant melanoma is the most aggressive and deadly form of skin cancer.
Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in …